HepaRegeniX GmbH

📍 Tübingen, Germany🗓 Founded 2017👥 15 employees💰 Last funded Mar 2025
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
5
Total investors
3
Early stage
1
Mid stage
1
Late stage
2017
Founded
Investor geography2 countries
Germany
4
Denmark
1
Investor activity2016–2025 · investors recorded per year
20162201912022120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in HepaRegeniX GmbH?
HepaRegeniX GmbH has 5 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did HepaRegeniX GmbH last raise funding?
The most recent investment in HepaRegeniX GmbH recorded on gritt.io was in March 2025.
When was HepaRegeniX GmbH founded?
HepaRegeniX GmbH was founded in 2017.
What industry is HepaRegeniX GmbH in?
HepaRegeniX GmbH operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HepaRegeniX GmbH based?
HepaRegeniX GmbH is headquartered in Tübingen, Germany.